Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000040

Director sold 68,142 shares at an average $33.09 ($2,254,951)

  • Director acquired 68,142 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schenkein David P · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-23 Exercise or conversion : show line 1 in the form +47,731 $31.64 $1,510,209 170,585 D
2024-02-23 Sale : show line 2 in the form −47,731 $33.05 $1,577,510 122,854 D
2024-02-26 Exercise or conversion : show line 3 in the form +20,411 $31.64 $645,804 143,265 D
2024-02-26 Sale : show line 4 in the form −20,411 $33.19 $677,441 122,854 D
Open-market sales · 68,142 sh · avg $33.09 · $2,254,951

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-02-23 Exercise or conversion : show line 5 in the form Stock option (right to buy) −47,731 89,740 D
2024-02-26 Exercise or conversion : show line 6 in the form Stock option (right to buy) −20,411 69,329 D
Loading xslF345X05/wk-form4_1709067874.xml…